Quantitation of angiogenesis and antiangiogenesis in vivo, ex vivo and in vitro - An overview

Altex

Volumn 26, Issue 2, 2009, Pages 95-107

  Bahramsoltani, Mahtab ^a   Plendl, Johanna ^a   Janczyk, Pawel ^a   Custodis, Pia ^a   Kaessmeyer, Sabine ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Angiogenesis; Antiangiogenesis; Ex vivo and in vitro models; In vivo; Quantitation

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; SURAMIN;

ANGIOGENESIS; ANIMAL WELFARE; ANTIANGIOGENIC ACTIVITY; BASEMENT MEMBRANE; CELL IMMORTALIZATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; COMPUTER ASSISTED TOMOGRAPHY; ENDOTHELIUM CELL; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGANOGENESIS; PAIN; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; STRESS; TISSUE DIFFERENTIATION;

ANGIOGENESIS INHIBITORS; ANIMAL TESTING ALTERNATIVES; ANIMALS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 70349479324     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. Abshagen, K., Schrodi, L, Gerber, T. and Vollmar, B. (2008). In vivo analysis of biocompatibility and vascularization of the synthetic bone grafting substitute NanoBone(R). J. Biomed. Mater. Res. A., E-pub ahead of print.
2. Akimoto, T., Liapis, H. and Hammerman, M. R. (2002). Microvessel formation from mouse embryonic aortic expiants is oxygen and VEGF dependent. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 283, R487-R495. (Pubitemid 34863897)
3. Algire, G. H. (1943). An adaption of the transparent-chamber technique to the mouse. J. Natl. Cancer Inst. USA 4, 1-11.
4. Auerbach, R. (2002). Angiogenesis assays. Trends Mol. Med. 8, 243.
5. Auerbach, R., Akhtar, N., Lewis, R. L. and Shinners, B. L. (2000). Angiogenesis assays: Problems and pitfalls. Cancer Metastasis Rev. 19, 167-172. (Pubitemid 32004706)
6. Auerbach, R., Auerbach, W. and Polakowski, I. (1991). Assays for angiogenesis: a review. Pharmacol. Ther. 51, 1-11.
7. Auerbach, R., Kubai, L., Knighton, D. and Folkman, J. (1974). A simple procedure for the long-term cultivation of chicken embryos. Dev. Biol. 41, 391-394.
8. Auerbach, R., Lewis, R., Shinners, B. et al. (2003). Angiogenesis assays: a critical overview. Clin. Chem. 49, 32-40. (Pubitemid 36078551)
9. Auerbach, W. and Auerbach, R. (1994). Angiogenesis inhibition: a review. Pharmacol. Ther. 63, 265-311. (Pubitemid 24315751)
10. Ausprunk, D. H., Knighton, D. R. and Folkman, J. (1975). Vascularization of normal and neoplastic tissues grafted to the chick chorioallantois. Role of host and preexisting graft blood vessels. Am. J. Pathol. 79, 597-628.
11. Babaei, S. and Stewart, D. J. (2002). Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model. Cardiovasc. Res. 55, 190-200. (Pubitemid 34615953)
12. Bahramsoltani, M., Käßmeyer, S. and Plendl, J. (2006). A novel quantitative in vitro model of angiogenesis. ALTEX 23 Suppl., 265-269.
13. Bahramsoltani, M. and Plendl, J. (2004). A new in vitro model to quantify angiogenesis. ALTEX 21, 227-244. (Pubitemid 40074948)
14. Bahramsoltani, M. and Plendl, J. (2007). Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis. APMIS 115, 30-46. (Pubitemid 46066572)
15. Basaki, Y., Chikahisa, L., Aoyagi, K. et al. (2001). γ- Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by Vascular Endothelial Growth Factor. Angiogenesis 4, 163-173. (Pubitemid 34174305)
16. Bell, E. J. and Brickell, P. M. (1997). Replication-competent retroviral vectors for expressing genes in avian cells in vitro and in vivo. Mol. Biotechnol. 7, 289-298. (Pubitemid 127498408)
17. Blacher, S., Devy, L., Burbridge, M. F. et al. (2001). Improved quantification of angiogenesis in the rat aortic ring assay. Angiogenesis 4, 133-142. (Pubitemid 34032699)
18. Blackwell, K. L., Haroon, Z. A., Shan, S. et al. (2000). Tamoxifen inhibits angiogenesis in estrogen receptor-negative animal models. Clin. Cancer Res. 6, 4359-4364.
19. Boyden, S. (1962). The chemotactic effect of mixture of antibody antigen on polymorphonuclear leukocytes. J. Exp. Med. 115, 453-466.
20. Brown, K. J., Maynes, S. F., Bezos, A. et al. (1996). A novel in vitro assay for human angiogenesis. Lab. Invest. 75, 539-555. (Pubitemid 26346804)
21. Brooks, P. C., Montgomery, A. M. and Cheresh, D. A. (1999). Use of 10-day-old chick embryo model for studying angiogenesis. Meth. Mol. Biol. 129, 257-269.
22. Bruns, C. J., Liu, W., Davis, D. W. et al. (2000). Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases. Cancer 89, 488-499. (Pubitemid 30640095)
23. Cao, R., Brankenhielm, E., Li, X. et al. (2002). Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and alphabeta receptors. FASEB 16, 1575-1583. (Pubitemid 35154640)
24. Célérier, J., Cruz, A., Lammandé, N. et al. (2002). Angiotensinogen and its cleavage derivatives inhibit angiogenesis. Hypertension 39, 224-235.
25. Collen, A., Koolwijk, P., Kroon, M. and van Hinsbergh, W. M. (1998). Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis 2, 153-165. (Pubitemid 128511983)
26. Connolly, J. O., Simpson, N., Hewlett, L. and Hall, A. (2002). Rac regulates endothelial morphogenesis and capillary assembly. Mol. Biol. Cell 13, 2474-2485. (Pubitemid 34831349)
27. Cross, L. M., Cook, M. A., Lin, S. et al. (2003). Rapid analysis of angiogenesis drugs in a live fluorescent zebrafish assay. Arterioscler. Thromb. Vasc. Biol. 23, 911-912. (Pubitemid 36566186)
28. Denis, F., Bougnoux, P., de Poncheville, L. et al. (2002). In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours. Ultrasound. Med. Biol. 28,431-437. (Pubitemid 34603762)
29. Dong, Z., Neiva, K. G., Jin, T. et al. (2007). Quantification of human angiogenesis in immunodeficient mice using a photon counting-based method. Biotechniques 43, 73-77. (Pubitemid 47092755)
30. Doukas, C. N., Maglogiannis, I., Chatziioannou, A. and Papapetropoulos, A. (2006). Automated angiogenesis quantification through advanced image processing techniques. Conf. Proc. IEEE Eng. Med. Biol. Soc. 1, 2345-2348. (Pubitemid 46520375)
31. Endrich, B., Asaishi, K., Goetz, A. and Messmer, K. (1980). Technical report - a new chamber technique for microvascular studies in unanaesthetized hamsters. Res. Exp. Med. 177, 125-134. (Pubitemid 11238699)
32. Ergün, S., Kilic, N., Wurmbach, J.-H. et al. (2001). Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes. Angiogenesis 4, 193-206. (Pubitemid 34174308)
33. Eriksson, J. and Löfberg, J. (2000). Development of the hypochord and dorsal aorta in the zebrafish embryo (Danio rerio). J. Morph. 244, 167-176. (Pubitemid 30392769)
34. Feldner, J., Becker, T., Goishi, K. et al. (2005). Neuropilin-1a is involved in trunk motor axon outgrowth in embryonic zebrafish. Dev. Dyn. 234, 535-549. (Pubitemid 41532976)
35. Gaudric, A., N'guyen, T., Moenner, M. et al. (1992). Quantification of angiogenesis due to basic fibroblast growth factor in a modified rabbit corneal model. Ophthalmic. Res. 24, 181-188.
36. Gimbrone, M. A. Jr., Cotran, R. S., Leapman, S. B. and Folkman, J. (1974). Tumor growth and neovascularisation: an experimental model using the rabbit cornea. J. Natl. Cancer Inst. USA 52, 413-419.
37. Guo, L., Burke, P., Lo, S.-H. et al. (2001). Quantitative analysis using confocal laser scanning microscopy. Angiogenesis 4, 187-191. (Pubitemid 34174307)
38. Hata, Y., Miura, M., Nakao, S. et al. (2008). Antiangiogenic properties of fasudil, a potent Rho-kinase inhibitor. Jpn. J. Ophthalmol 52, 16-23. (Pubitemid 351462217)
39. Henkind, P. (1978). Ocular neovascularisation. Am. J. Ophthal. 85, 287-301.
40. Harvey, K., Welch, Z., Kovola, T. et al. (2002). Comparative analysis of in vitro angiogenic activities of endothelial cells of heterogeneous origin. Microvasc. Res. 63, 316-326. (Pubitemid 34971627)
41. Hoffmann, J., Schirner, M., Menrad, A. and Schneider, M. R. (1997). Ahighly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res. 57, 3847-3851. (Pubitemid 27381234)
42. Hoying, J. B. and Williams, S. K. (1996). Measurement of endothelial cell migration using an improved linear migration assay. Microcirculation 3, 167-174.
43. Huang, S.-M., Li, J., Armstrong, E.A. and Harari, P.M .(2002). Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD 1839 (Iressa). Cancer Res. 62, 4300-4306. (Pubitemid 34827286)
44. Iwahana, M., Nakayama, Y., Tanaka, N.G. et al. (1996). Quantification of tumour-induced angiogenesis by image analysis. Int. J. Exp. Path. 77, 109-114. (Pubitemid 26266396)
45. Jabbour, M. N., Elder, J. B., Samuelson, C. G. et al. (2009). Aberrant angiogenic characteristics of human brain arteriovenous malformation endothelial cells. Neurosurgery 64, 139-146.
46. Jain, R. K., Schlenger, K., Höckel, M. and Ynan, F. (1997). Quantitative angiogenesis assays: Progress and problems. Nature Med. 3, 1203-1208. (Pubitemid 27508819)
47. Joussen, A. M., Germann, T. and Kirchhof, B. (1999). Effect of thalidomide and structurally related compounds on corneal angiogenesis is comparable to their teratological potency. Graefe's Arch. Clin. Exp. Ophthalmol. 237, 952-961. (Pubitemid 30021284)
48. Jung, M. H., Lee, S. H., Ahn, E. M. and Lee, Y. M. (2009). Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR2 signaling pathway. Carcinogenesis, E-pub ahead of print.
49. Jung, S. P., Siegrist, B., Wade, M. R. et al. (2001). Inhibition of human angiogenesis with heparin and hydrocortisone. Angiogenesis 4, 175-186. (Pubitemid 34174306)
50. Kazanskaya, O., Ohkawara, B., Heroult, M. et al. (2008). The Wnt signaling regulator R-spondin 3 promotes angioblast and vascular development. Development 135, 3655-3664.
51. Kiessling, F., Huppert, J. and Palmowski, M. (2009). Functional and molecular ultrasound imaging: concepts and contrast agents. Curr. Med. Client. 16, 627-642.
52. Knighton, D. R., Fiegel, V. D. and Phillips, G. D. (1991). The assays for angiogenesis. Progr. Clin. Biol. Res. 365, 291-299.
53. Kruger, E. A., Duray, P. H., Price, D. K. et al. (2001). Approaches to preclinical screening of antiangiogenic agents. Sem. Oncology 28, 570-576. (Pubitemid 33134416)
54. Kruger, E. A. and Figg, W. D. (2001). Protein binding alters the activity of Suramin, Carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay. Clin. Cancer Res. 7, 1867-1872. (Pubitemid 32994819)
55. Kueng, W., Silber, E. and Eppenberger, U. (1989). Quantification of cells cultured on 96-well plates. Anal. Biochem. 182, 16-19. (Pubitemid 19251274)
56. Kuzuya, M., Satake, S., Ai, S. et al. (1998). Inhibition of angiogenesis on glycated collagen lattices. Diabetologia 41, 491-499. (Pubitemid 28206817)
57. Lang, I., Hoffmann, C., Olip, H. et al. (2000). Differential mitogenic responses of human macrovascular and microvascular endothelial cells to cytokines underline their phenotypic heterogeneity. Cell Prolif. 34, 143-155. (Pubitemid 32523216)
58. Lange, S., Heger, J., Euler, G. et al. (2009). Platelet-derived growth factor BB stimulates vasculogenesis of embryonic stem cell-derived endothelial cells by calcium-mediated generation of reactive oxygen species. Cardiovasc. Res. 81, 159-168.
59. Langer, R. and Folkman, J. (1976). Polymers for the sustained release of proteins and other macromolecules. Nature 263, 797-799.
60. Lawson, N. D. and Weinstein, B. M. (2002). In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev. Biol. 248, 307-318. (Pubitemid 35002091)
61. Lee, P., Goishi, K., Davidson, A. J. et al. (2002). Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. Proc. Natl. Acad. Sci. USA 99, 10470-10475.
62. Lehr, H. A., Leunig, M., Menger, M. D. et al. (1993). Dorsal skinfold chamber technique for intravital microscopy in nudemice. Am. J. Pathol. 143, 1055-1062. (Pubitemid 24070548)
63. Lenander, C. and Holmgren, L. (1999). A novel method of visualizing vessels in human tumor biopsies. Angiogenesis 3, 291-293. (Pubitemid 129643971)
64. Liapakis, I. D., Anagnostoulis, S., Karayiannakis, A. J. et al. (2008). Recombinant leptin administration improves early in full-thickness skin flaps: an experimental study. In Vivo 22, 247-252. (Pubitemid 351523563)
65. Lichtenberg, J., Hansen, C. A., Skak-Nielsen, T. et al. (1997). The rat subcutaneus air sac model: a new and simple method for in vivo screening of antiangiogenesis. Pharmacol. Toxicol. 81, 280-284. (Pubitemid 27511673)
66. Lichtenberg, J., Hjarnaa P.-J., Kristjansen, P. E. et al. (1999). The rat subcutaneus air sac model: a quantitative assay of antiangiogenesis in induced vessels. Pharmacol. Toxicol. 84, 34-40. (Pubitemid 29069237)
67. Limaye, V., Xia, P., Hahn, C. et al. (2009). Chronic increases in sphingosine kinase-1 activity induce a pro-inflammatory, pro-angiogenic phenotype in endothelial cells. Cell Mol. Biol. Lett., E-pub ahead of print.
68. Lindner, R. J. (2004). Molecular imaging with contrast ultrasound and targeted microbubbles. J. Nucl. Cardiol. 11, 215-221.
69. Liu, Y, Sainz, I. M., Pixley, R. et al. (2008). The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases. Exp. Cell Res. 314, 774-788.
70. Lucidarme, O., Kono, Y., Corbeil, J. et al. (2006). Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model. Radiology 239, 730-739. (Pubitemid 43830608)
71. Ma, A. Ch., Lin, R., Chan, P.-K. et al. (2007). The role of survivin in angiogenesis during zebrafish embryonic development. BMC Dev. Biol. 7, 50.
72. McDonald, D. M. and Choyke, P. L. (2003). Imaging of angiogenesis: from microscope to clinic. Nat. Med. 9, 713-725. (Pubitemid 36749220)
73. Menger, M. D., Laschke, M. W. and Vollmar, B. (2002). Viewing the microcirculation through the window: some twenty years experience with the hamster dorsal skinfold chamber. Eur. Surg. Res. 34, 83-91. (Pubitemid 34195702)
74. Meyer, G. T., Matthias, L. J., Noack, L. et al. (1997). Lumen formation during angiogenesis in vitro involves phagocytic activity, formation and secretion of vacuoles, cell death, and capillary tube remodelling by different populations of endothelial cells. Anat. Rec. 249, 327-340. (Pubitemid 27469284)
75. Minici, F., Miceli, F., Tiberi, F. et al. (2007). Ghrelin in vitro modulates vasoactive factors in human umbilical vein endothelial cells. Fertil. Steril. 88, 1158-1166. (Pubitemid 47513052)
76. Minischetti, M., Vacca, A., Ribatti, D. et al. (2000). TNP-470 and recombinant human interferon-α2a inhibit angiogenesis synergistically. Brit. J. Haemat. 109, 829-837. (Pubitemid 30609764)
77. Montanez, E., Casaroli-Marano, R. P., Vilaro, S. and Pagan, R. (2002). Comparative study of tube assembly in three-dimensional collagen matrix and on Matrigel coats. Angiogenesis 5, 167-172. (Pubitemid 36687519)
78. Montesano, R., Vassalli, J. D., Baird, A. et al. (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proc. Natl. Acad. Sci. USA 83, 7297-7301. (Pubitemid 16000508)
79. Mountain, D. J., Singh, M. and Singh, K. (2008). Interleukin-1 beta-mediated inhibition of the process of angiogenesis in cardiac microvascular endothelial cells. Life Sci., E-pub ahead of print.
80. Murohara, T., Witzenbichler, B., Spridopoulos, I. et al. (1999). Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler. Thromb. Vasc. Biol. 19, 1156-1161. (Pubitemid 29227632)
81. Nehls, V. and Drenckhahn, D. (1995). A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc. Res. 50, 311-322.
82. Nguyen, M., Shing, Y. and Folkman, J. (1994). Quantitation of angiogenesis and antiangiogenesis in the chick chorioallantoic membrane. Microvasc. Res. 47, 31-40. (Pubitemid 24194854)
83. Nicosia, R. F. and Ottinetti, A. (1990a). Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115-122. (Pubitemid 20234680)
84. Nicosia, R. F. and Ottinetti, A. (1990b). Modulation of microvascular growth and morphogenesis by reconstituted basement membrane gel in three-dimensional cultures of rat aorta: a comparative study of angiogenesis in matrigel, collagen, fibrin, and plasma clot. In Vitro Cell Dev. Biol. 26, 119-128. (Pubitemid 20094385)
85. Ny, A., Autiero, M. and Carmeliet, P. (2006). Zebrafish and Xenopus tadpoles: Small animal models to study angiogenesis and lymphangiogenesis. Exp. Cell Res. 312, 684-693. (Pubitemid 43290345)
86. Ober, E. A., Olofsson, B., Mäkinen, T. et al. (2004). Vegfc is required for vascular development and endoderm morphogenesis in zebrafish. EMBO Rep. 5, 78-84. (Pubitemid 38228532)
87. Oikawa, T., Sasaki, M., Inose, M. et al. (1997). Effects of cyogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. Anticancer Res. 17, 1881-1886. (Pubitemid 27320921)
88. Papenfuss, H. D., Gross, J. F., Intaglietta, M. and Treese, F. A. (1979). A transparent access chamber for the rat dorsal skin fold. Microvasc. Res. 18, 311-318. (Pubitemid 10180862)
89. Peters, K., Schmidt, H., Unger, R. E. et al. (2002). Software-supported image quantification of angiogenesis in an in vitro culture system: application to studies of biocompatibility. Biomaterials 23, 3413-3419. (Pubitemid 34615647)
90. Plunkett, M. L. and Hailey, J. A. (1990). An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab. Invest. 62, 510-517. (Pubitemid 20154330)
91. Ramsauer, M., Krause, D. and Dermietzel, R. (2002). Angiogenesis of the blood-brain barrier in vitro and the function of cerebral pericytes. FASEB 16, 1274-1276.
92. Ribatti, D., Crivellato, E., Candussio, L. et al. (2002). Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human α-2a interferon and partly mediated by fibroblast growth factor-2. Haematologica 87, 465-471. (Pubitemid 34533270)
93. Ribatti, D., Gualandris, A., Bastaki, M. et al. (1997). New model for the study of angiogenesis and antiangiogenesis in the chick chorioallantoic membrane: the gelatin sponge / chorioallantoic membrane assay. J. Vasc. Res. 34, 455-463. (Pubitemid 28008032)
94. Ribatti, D., Nico, B., Vacca, A. et al. (2001). Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo. Anat. Rec. 264, 317-324. (Pubitemid 33097031)
95. Ribatti, D., Vacca, A., Roucali, L. and Damacco, F. (1996). The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int. J. Dev. Biol. 40, 1189-1197. (Pubitemid 27072813)
96. Rubinstein, A. L. (2003). Zebrafish: from disease modeling to drug discovery. Curr. Opin. Discov. Devel. 6, 218-223.
97. Runkel, S., Hunter, N. and Milas, L. (1991). An intradermal assay for quantification and kinetic studies of tumor angiogenesis in mice. Radiation Res. 126, 237-243.
98. Saiki, A., Watanabe, F., Murano, T. et al. (2006). Hepatocyte growth factor secreted by cultured adipocytes promotes tube formation of vascular endothelial cells in vitro. Int. J. Obes. (Lond) 30, 1676-1684. (Pubitemid 44657843)
99. Sankar, S., Mahooti-Brooks, N., Bensen, L. et al. (1996). Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 97, 1436-1446. (Pubitemid 26097033)
100. Schor, A. M., Schor, S. L. and Allen, T. D. (1983). Effects of culture conditions on the proliferation, morphology and migration of bovine aortic endothelial cells. J. Cell Sci. 62, 267-285.
101. Schwerte, T. and Pelster, B. (2000). Digital motion analysis as a tool for analyzing the and performance of the circulatory system in transparent animals. J. Exp. Biol. 203, 1659-1669. (Pubitemid 30400196)
102. Semba, T., Funahashi, Y., Naoto, O. et al. (2004). An angiogenesis inhibitor E7820 shows broad-spectrum tumor growth inhibition in a xenograft model: possible value of integrin alpha2 on platelets as a biological marker. Clin. Cancer Res. 10, 1430-1438. (Pubitemid 38365238)
103. Serbedzija, G. N., Flynn, E. and Willet, C. E. (1999). Zebrafish angiogenesis: A new model for drug screening. Angiogenesis 3, 353-359. (Pubitemid 129643978)
104. Shan, S., Lockhart, A. C., Saito, W. Y. et al. (2001). The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats. Clin. Cancer Res. 7, 2590-2596. (Pubitemid 32751666)
105. Sheu, J. R., Fu, C. C., Tsai, M. L. and Chung, W. J. (1998). Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities. Anticancer Res. 18, 4435-4441. (Pubitemid 29043673)
106. Shichiri, M. and Hirata, Y. (2001). Antiangiogenesis signals by endostatin. FASEB 15, 1044-1053. (Pubitemid 32290793)
107. Shrader, C. D., Bailey, K. M., Konat, G. W. et al. (2009). Insulin enhances proliferation and viability of human umbilical vein endothelial cells. Arch. Dermatol. Res. 301, 159-166.
108. Spanel-Borowski, K., Schnapper, U. and Heymer, B. (1988). The chick chorioallantoic membrane assay in the assessment of angiogenic factors. Biomed. Res. 9, 253-260.
109. Staton, C. A., Brown, N. J., Rodgers, G. R. et al. (2004). Alphastatin, a 24-amino acid fragment of human fibrinogen, is potent new inhibitor of activated endothelial cells in vitro and in vivo. Blood 103, 601-606. (Pubitemid 38140093)
110. Tong, S., Chen, Q., Shan, S.Q. et al. (2006). Quantitative comparison of the inhibitory effects of GW5638 and tamoxifen on angiogenesis in the cornea pocket assay. Angiogenesis 9, 53-58. (Pubitemid 44440549)
111. Torres Filho, I. P., Hartley-Asp, B. and Borgström, P. (1995). Quantitative angiogenesis in a syngeneic tumor spheroid model. Microvasc. Res. 49, 212-226.
112. Ushiyama, A., Yamada, S. and Ohkubo, C. (2004). Microcirculatory parameters measured in subcutaneous tissue of the mouse using a novel dorsal skinfold chamber. Microvasc. Res. 68, 147-152. (Pubitemid 39093889)
113. Vailhé, B., Vittet, D. and Feige, J.-J. (2001). In vitro models of vasculogenesis and angiogenesis. Lab. Invest. 81, 439-452. (Pubitemid 32298789)
114. Vajkoczy, P., Thurnher, A., Hirth, K. P. et al. (2000). Measuring VEGF-Flk-1 activity and consequences in vivo using intravital microscopy: clinical applications. The Oncologist 5, 16-19. (Pubitemid 30225452)
115. Vasse, M., Pourtan, J., Trochon, V. et al. (1999). Oncostatin M induces angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 19, 1835-1842. (Pubitemid 29379912)
116. Velazquez, O. C., Snyder, R., Lin, Z.-J. et al. (2002). Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks. FASEB 16, 1316-1318.
117. Vernon, R. B. and Sage, E. H. (1999). A novel, quantitative model for study of endothelial cell migration and sprout formation within three-dimensional collagen matrices. Microvasc. Res. 57, 118-133. (Pubitemid 29393289)
118. Vollmar, B., Laschke, M. W., Rohan, R. et al. (2001). In vivo imaging of physiological angiogenesis from immature to preovulatory ovarian follicles. Am. J. Path. 159, 1661-1670. (Pubitemid 33062509)
119. Wang, X. H., Chen, S. F., Jin, H. M. and Hu, R. M. (2009). Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats. Life Sci. 84, 240-249.
120. Wang, T. and Shi, W. (2009). Expression of fibroblast activation proteins in corneal stromal neovascularization. Curr. Eye Res. 34, 112-117.
121. Weis, M., Heeschen, C., Glassford, A. J. and Cooke, J. P. (2002). Statins have biphasic effects on angiogenesis. Circulation 105, 739.
122. Wild, R., Ramakrishnan, S., Sedgewick, J. and Griffioen, A. W. (2000). Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc. Res. 59, 368-376. (Pubitemid 30322264)
123. Willmann, J. K., Paulmurugan, R., Chen, K. et al. (2008). US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. Radiology 246, 508-518.
124. Yamamoto, K., Kimura, T., Sugitachi, A. and Matsuura, N. (2009). Anti-angiogenic and anti-metastatic effects of beta-1,3-D-glucan purified from Hanabiratake, Sparassis crispa. Biol. Pharm. Bull. 32, 259-263.
125. Yokoyama, Y., Dhanabal, M., Griffioen, A. W. et al. (2000). Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth. Cancer Res. 60, 2190-2196. (Pubitemid 30225182)
126. Yoon, S. S., Eto, H., Lin, C. et al. (1999). Mouse endostatin inhibits the formation of lung and liver metastases. Cancer Res. 59, 6251-6256. (Pubitemid 30035650)
127. Zhong, T. P., Childs, S., Leu, J. P. and Fishman, M. C. (2001). Gridlock signaling pathway fashions the first embryonic artery. Nature 414, 216-220. (Pubitemid 33051237)
128. Ziehe, M., Morbidelli, L., Masini, E. et al. (1994). Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94, 2036-2044. (Pubitemid 24348244)